Kraig Biocraft Laboratories (KBLB) Total Current Liabilities (2010 - 2026)

Kraig Biocraft Laboratories has reported Total Current Liabilities for 16 years, with the latest figure at $10.4 million in Q4 2025.

• Quarterly Total Current Liabilities rose 8.64% year-over-year to $10.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.4 million (up 8.64% YoY) and the FY2025 annual result came in at $10.4 million, up 8.64% from the prior year.
• Total Current Liabilities grew to $10.4 million in Q4 2025 per KBLB's latest filing, from $10.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $10.4 million in Q4 2025 and troughed at $7.8 million in Q1 2021.
• A 5-year average of $9.0 million and a median of $8.9 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2021 and 2023: Total Current Liabilities jumped 35.98% in 2021, then decreased 8.58% in 2023.
• Over 5 years, Total Current Liabilities stood at $8.2 million in 2021, then declined by 1.11% to $8.1 million in 2022, then advanced by 10.08% to $8.9 million in 2023, then rose by 8.2% to $9.6 million in 2024, then advanced by 8.64% to $10.4 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $10.4 million, $10.2 million, and $10.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.